Dividends & Buybacks ·
Tenon Medical, Inc. held its 2026 Annual Meeting of Stockholders on July 23, 2026, where shareholders approved several…
TNONTenon Medical, Inc.
Tenon Medical, Inc. held its 2026 Annual Meeting of Stockholders on July 23, 2026, where shareholders approved several key proposals. These included the election of seven directors, the ratification of Haskell & Whitee LLP as the independent auditor, and authorization for the Board to implement a reverse stock split with a ratio ranging from 1-for-2 to 1-for-35. Additionally, stockholders approved proposals regarding the issuance of common stock underlying convertible promissory notes from a March 2026 debt financing and rules governing future financings to comply with Nasdaq listing requirements. Tenon Medical, Inc. is a medical technology company.